Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Abel A Pavía-López, José A Magaña-Serrano, José A Cigarroa-López, Adolfo Chávez-Mendoza, José L Mayorga-Butrón, Diego Araiza-Garaygordobil, Juan B Ivey-Miranda, Gustavo F Méndez-Machado, Héctor González-Godínez, Luisa F Aguilera-Mora, Antonio Jordán-Ríos, Luis Olmos-Domínguez, Marcos J Olalde-Román, Emma M Miranda-Malpica, Zuilma Vázquez-Ortiz, Jorge Rayo-Chávez, Alexandra A Mendoza, Manlio F Márquez-Murillo, Sergio A Chávez-Leal, Amada Álvarez-San Gabriel, Marissa A Silva-García, Alex D Pacheco-Bouthiller, Jorge A Aldrete-Velazco, Carlos A Guizar-Sánchez, Efraín Gaxiola-López, Arturo Guerra-López, Lourdes Figueiras-Graillet, Gustavo Sánchez-Miranda, Genaro H Mendoza-Zavala, Moisés Aceves-García, Adolfo Chávez-Negrete, Marisol Arroyo-Hernández, Bertha B Montaño-Velázquez, Luis F Romero-Moreno, María M Baquero-Hoyos, Liliana Velasco-Hidalgo, Ana L Rodríguez-Lozano, Nancy E Aguilar-Gómez, Mario Rodríguez-Vega, Jorge E Cossío-Aranda
Chronic heart failure continues to be one of the main causes of impairment in the functioning and quality of life of people who suffer from it, as well as one of the main causes of mortality in our country and around the world. Mexico has a high prevalence of risk factors for developing heart failure, such as high blood pressure, diabetes, and obesity, which makes it essential to have an evidence-based document that provides recommendations to health professionals involved in the diagnosis and treatment of these patients...
2024: Archivos de Cardiología de México
#2
JOURNAL ARTICLE
Martín Alejandro Urtasun, Cristian Dorati, Martín Cañás, María Silvina Bruzzone, Gustavo H Marín, Nasim Iusef Venturini, Perla Mordujovich Buschiazzo
OBJECTIVE: Conduct an analysis to determine the existence and updating of national essential medicines lists (EMLs) and clinical practice guidelines (CPGs) for the treatment of diabetes in Latin America and the Caribbean (LAC); and compare the medicines included in each country's list and guidelines both with each other and with those of the World Health Organization (WHO). METHODS: Cross-sectional study. EMLs and CPGs for diabetes were found on the websites of the Pan American Health Organization and national health authorities...
2024: Pan American Journal of Public Health
#3
JOURNAL ARTICLE
Enrique Martín-Rioboó, Carlos Brotons-Cuixart, Antonio Ruiz García, Fátima Villafañe Sanz, Manuel Frías Vargas, Ana Moyá Amengual, Juan Antonio Divisón Garrote, María Cruz Seoane Vicente, José R Banegas, Vicente Pallarés Carratalá
General practitioners see in their consultation a a significant number of patients at high vascular risk (VR). The European Guidelines for Cardiovascular Disease Prevention (2021) recommend a new risk classification and intervention strategies on on vascular risk factors (RF), with the aim of providing a shared decision-making recommendations between professionals and patients. In this document we present a critical analysis of these guidelines, offering possible solutions that can be implemented in Primary Care...
August 16, 2023: Revista Española de Salud Pública
#4
JOURNAL ARTICLE
Carlos Brotons, Miguel Camafort, María Del Mar Castellanos, Albert Clarà, Olga Cortés, Ángel Diaz Rodríguez, Roberto Elosua, Manuel Gorostidi, Antonio M Hernández, María Herranz, Soledad Justo, Carlos Lahoz, Pilar Niño, Vicente Pallarés-Carratalá, Juan Pedro-Botet, Antonio Pérez Pérez, Miguel Ángel Royo-Bordonada, Rafael Santamaría, Ricard Tresserras, Alberto Zamora, Inés Zuza, Pedro Armario
We present the Spanish adaptation of the 2021 European Guidelines on Cardiovascular Disease (CVD) prevention in clinical practice. The current guidelines besides the individual approach greatly emphasize on the importance of population level approaches to the prevention of cardiovascular diseases. Systematic global CVD risk assessment is recommended in individuals with any major vascular risk factor. Regarding LDL-Cholesterol, blood pressure, and glycemic control in patients with diabetes mellitus, goals and targets remain as recommended in previous guidelines...
2023: Nefrología
#5
JOURNAL ARTICLE
J Ena, J Carretero-Gómez, J Manuel-Casas, P Casado, P Vázquez-Rodríguez, F Martínez-García, P González-González, B de Escalante-Yagüela, M Gandullo-Moro, F-J Carrasco-Sánchez
OBJECTIVES: Evaluation of quality of care for patients with diabetes mellitus admitted to hospitals in Spain. METHODS: Cross-sectional study in one day that included 1193 (26.7%) patients with type 2 diabetes or hyperglycaemia out of a total of 4468 patients admitted to the internal medicine departments of 53 hospitals in Spain. We collected demographic data, adequacy of capillary glycaemic monitoring, treatment administered during admission, and recommended therapy at discharge...
2023: Revista Clínica Espanõla
#6
Maria Leonor Guia Lopes, Carlos Bello, Lucília Carvalho, Clotilde Limbert, João Sequeira Duarte
Cushing's syndrome (CS) is a rare clinical entity that results from prolonged exposure to supraphysiological levels of glucocorticoids. It may result from adrenocorticotropic hormone (ACTH)-dependent or nondependent stimuli. In very rare cases, ACTH production does not derive from the pituitary gland but is of an ectopic origin. We present a case of a 51-year-old woman with cushingoid physical features, who was admitted to the emergency department with a hypertensive crisis, hyperglycemic state, and severe hypokalemia...
April 2023: Curēus
#7
JOURNAL ARTICLE
Rocío Villar-Taibo, Eva Fernández-Rodríguez, Cristina Tejera-Pérez, Carmen Díaz-Ortega, Paula Sánchez-Sobrino, Regina Palmeiro-Carballeira, Nazareth Rodríguez-Novo, Gemma Rodríguez-Carnero, Iria Pinal-Osorio, Laura Cotovad-Bellas, Olaia Díaz-Trastoy, Beatriz Mantiñán-Gil, Paula Álvarez-Castro, Paula Andújar Plata, Inés Seoane-Cruz, Alma Prieto-Tenreiro, Rosa Argüeso Armesto, Antía Fernández-Pombo, Ana Sánchez-Bao, Alfonso Vidal-Casariego
AIM: To assess the degree of compliance with the European ESC/EAS 2016 and 2019 dyslipidaemia guidelines in patients with type 2 diabetes mellitus (T2DM). METHODS: Multicentre retrospective cross-sectional study, conducted in 380 adults with T2DM and dyslipidaemia in 7 Spanish health areas. INCLUSION CRITERIA: minimum follow-up of one year in Endocrinology Units, at least one visit in 2020 and a lipid profile measurement in the last 3 months...
January 2023: Endocrinología, diabetes y nutrición
#8
Antony Soares Dionísio, Joana Duarte, Maria Leonor Guia Lopes, Cristiana Camacho
Fournier's gangrene (FG) is an infectious disease characterized by necrotizing fasciitis of the perineal, perianal, or genital area associated with aging, male gender, diabetes mellitus (DM), alcoholism, trauma, and immunosuppression states. It can rapidly evolve into sepsis, septic shock, and multiorgan failure with a high mortality rate. We present the case of a 55-year-old man who developed a severe FG, initially assumed as an epididymo-orchitis with new-onset DM. The early identification and treatment resulted in a favorable outcome, being discharged from the hospital after 21 days...
December 2022: Curēus
#9
David E Barajas Galindo, Jorge Gabriel Ruiz-Sánchez, Alberto Fernández Martínez, Isabelle Runkle de la Vega, Juan Carlos Ferrer García, Guillermo Ropero-Luis, Ana Ortolá Buigues, Joaquín Serrano Gotarredona, Emilia Gómez Hoyos
INTRODUCTION: Hyponatremia is the most prevalent electrolyte disorder in the outpatient and inpatient settings. Despite this frequency, hyponatremia, including severe hyponatremia, is frequently underestimated and inadequately treated, thus highlighting the need to produce consensus documents and clinical practice guidelines geared towards improving the diagnostic and therapeutic approach to it in a structured fashion. MATERIAL AND METHODS: Members of the Acqua Group of the Spanish Society of Endocrinology and Nutrition (SEEN) met using a networking methodology over a period of 20 months (between October 2019 and August 2021) with the aim of discussing and developing an updated guideline for the management of hyponatraemia...
March 2023: Endocrinología, diabetes y nutrición
#10
JOURNAL ARTICLE
Carlos Brotons, Miguel Camafort, María Del Mar Castellanos, Albert Clarà, Olga Cortés, Angel Diaz Rodriguez, Roberto Elosua, Manuel Gorostidi, Antonio M Hernández, María Herranz, Soledad Justo, Carlos Lahoz, Pilar Niño, Vicente Pallarés-Carratalá, Juan Pedro-Botet, Antonio Pérez Pérez, Miguel Angel Royo-Bordonada, Rafael Santamaria, Ricard Tresserras, Alberto Zamora, Inés Zuza, Pedro Armario
We present the Spanish adaptation of the 2021 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. The current guidelines besides the individual approach greatly emphasize on the importance of population level approaches to the prevention of cardiovascular diseases. Systematic global cardiovascular disease risk assessment is recommended in individuals with any major vascular risk factor. Regarding LDL-cholesterol, blood pressure, and glycemic control in patients with diabetes mellitus, goals and targets remain as recommended in previous guidelines...
July 2022: Clínica e Investigación en Arteriosclerosis
#11
JOURNAL ARTICLE
Manuel Mateu-Salat, Jesús Moreno-Fernández, Natalia Mangas, Idoia Genua, María José Martínez, Alicia López, Cintia González, Ana Chico
The Flash Guide (FG) for insulin dosing (A. Chico, C. González) was the first document intended for FreeStyle Libre® (FSL) user patients to help with decision-making depending on glucose level and trend. The objective of the study was to evaluate the usefulness of and the level of satisfaction with the recommendations given by the FG in a group of patients with type 1 diabetes (DM1) who were FSL users. It included 31 subjects (54% women; age 41 ± 15 years; DM duration 21 ± 14 years; 22 with FSL > 12 months) who were provided with the FG...
May 13, 2022: Endocrinología, diabetes y nutrición
#12
C Brotons, M Camafort, M Del Mar Castellanos, A Clarà, O Cortés, A Diaz Rodriguez, R Elosua, M Gorostidi, A M Hernández, M Herranz, S Justo, C Lahoz, P Niño, V Pallarés-Carratalá, J Pedro-Botet, A Pérez Pérez, M A Royo-Bordonada, R Santamaria, R Tresserras, A Zamora, I Zuza, P Armario
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. We present the Spanish adaptation of the 2021 European Guidelines on Cardiovascular Disease (CVD) prevention in clinical practice. The current guidelines besides the individual approach greatly emphasize on the importance of population level approaches to the prevention of cardiovascular diseases. Systematic global CVD risk assessment is recommended in individuals with any major vascular risk factor...
March 21, 2022: Hipertensión y Riesgo Vascular
#13
JOURNAL ARTICLE
David Martín Enguix, Abraham Hidalgo Rodríguez, María Sánchez Cambronero, Juan Carlos Aguirre Rodríguez
BACKGROUND AND OBJECTIVE: Cardiovascular disease is one of the main complications of people with type 2 diabetes (T2D). The ESC/ESA 2019 lipid guide has led to a change in dyslipidemia control. We analyze the evolution of the lipid profile, the fulfillment of the low-density cholesterol (LDL-C) targets, how patients are classified and the impact of this guide on lipid control in T2D patients. MATERIALS AND METHODS: A prospective cohort study from 2017 to 2020 from a cohort of 297 T2D out of a total of 1229 (95% confidence level)...
January 2022: Clínica e Investigación en Arteriosclerosis
#14
Manuel Gargallo-Fernández, Javier Escalada-San Martín, Ana Chico-Ballesteros, Edurne Lecumberri-Pascual, Cristina Tejera-Pérez, José Carlos Fernández-García, Pedro Rozas-Moreno, Amparo Marco-Martínez, Fernando Gómez-Peralta, Judith López-Fernández
No abstract text is available yet for this article.
September 3, 2021: Endocrinología, diabetes y nutrición
#15
JOURNAL ARTICLE
Manuel Mateu-Salat, Jesús Moreno-Fernández, Natalia Mangas, Idoia Genua, María José Martínez, Alicia López, Cintia González, Ana Chico
The Flash Guide (FG) for insulin dosing (A. Chico, C. González) was the first document intended for FreeStyle Libre® (FSL) user patients to help with decision-making depending on glucose level and trend. The objective of the study was to evaluate the usefulness of and the level of satisfaction with the recommendations given by the FG in a group of patients with type 1 diabetes (DM1) who were FSL users. It included 31 subjects (54% women; age 41±15 years; DM duration 21±14 years; 22 with FSL>12 months) who were provided with the FG...
August 24, 2021: Endocrinología, Diabetes y Nutrición
#16
JOURNAL ARTICLE
Lizbeth Tolentino-Mayo, Janine Sagaceta-Mejía, Carlos Cruz-Casarrubias, Víctor Ríos-Cortázar, Alejandra Jauregui, Simón Barquera
OBJECTIVE: Evaluate the use, subjective and objective under-standing of the GDA frontal labeling to assist the population towards making healthy decisions regarding the products they consume. MATERIALS AND METHODS: The use of nu-tritional information contained in products ́ packages (GDA, nutritional information table, and list of ingredients), as well as the subjective and objective comprehension of the GDA. RESULTS: A total of 43 157 people were interviewed...
November 2020: Salud Pública de México
#17
JOURNAL ARTICLE
Pedro Armario, Carlos Brotons, Roberto Elosua, Maria Alonso de Leciñana, Almudena Castro, Albert Clarà, Olga Cortés, Ángel Díaz Rodriguez, María Herranz, Soledad Justo, Carlos Lahoz, Juan Pedro-Botet, Antonio Pérez Pérez, Rafael Santamaria, Ricard Tresserras, Susana Aznar Lain, Miguel Ángel Royo-Bordonada
We present the adaptation for Spain of the updated European Cardiovascular Prevention Guidelines. In this update, greater stress is laid on the population approach, and especially on the promotion of physical activity and healthy diet through dietary, leisure and active transport policies in Spain. To estimate vascular risk, note should be made of the importance of recalibrating the tables used, by adapting them to population shifts in the prevalence of risk factors and incidence of vascular diseases, with particular attention to the role of chronic kidney disease...
March 2021: Clínica e Investigación en Arteriosclerosis
#18
(no author information available yet)
The present revision of the Guide for the diagnosis and treatment of patients with cystic fibrosis published in 2014 aims to update the knowledge about various aspects related to the clinical management of the disease, according to the scientific advances published and in development in recent years. Only new topics will be discussed here and those that, in light of the research, require modification, so the content of the previous guide remains valid in the rest of the aspects. The updated aspects range over the diagnosis of the disease due to the changes made in the sweat test, the neonatal screening and molecular biology, the update of follow-up studies, such as the Lung Clearance Index and the Nuclear Magnetic Resonance, and modifications regarding the nutritional area (diabetes secondary to cystic fibrosis) and the physiotherapy treatment and pulmonary rehabilitation...
February 2021: Archivos Argentinos de Pediatría
#19
REVIEW
María Martinez-Ferran, Fernando de la Guía-Galipienso, Fabián Sanchis-Gomar, Helios Pareja-Galeano
While the detrimental effects of a chronic positive energy balance due to a sedentary lifestyle have been well established, the impacts of a short period of abruptly reduced physical activity and overeating arising from strict confinement due to the COVID-19 pandemic will soon start to emerge. To reasonably anticipate major consequences according to the available evidence, we hereby review the literature for studies that have explored the health impacts of several weeks of a reduction in physical activity and daily step-count combined with modified eating habits...
May 26, 2020: Nutrients
#20
JOURNAL ARTICLE
Michelle T Alves, Amanda C S Chaves, Ana Paula M Almeida, Ana Cristina Simões E Silva, Stanley de A Araújo, Ana Paula L Mota, Thiago R Dos Mares-Guia, Ana Paula Fernandes, Karina B Gomes
Type 1 diabetes mellitus (T1DM) is characterized by C-peptide deficiency and elevated levels of pro-inflammatory cytokines. The aim of this study was to investigate the role of C-peptide in renal and inflammatory complications in streptozotocin (STZ)-diabetic mice model of T1DM with kidney disease. The study was performed in 8-week old male C57BL/6 mice. Two streptozotocin-diabetic groups (a T1DM animal model), after 4 weeks of diabetes, were treated with subcutaneous infusion of either vehicle (n = 12) or C-peptide (n = 11)...
January 2020: Molecular Biology Reports
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
